BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 11079534)

  • 21. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.
    Baird AE; Benfield A; Schlaug G; Siewert B; Lövblad KO; Edelman RR; Warach S
    Ann Neurol; 1997 May; 41(5):581-9. PubMed ID: 9153519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
    Ribo M; Molina CA; Delgado P; Rubiera M; Delgado-Mederos R; Rovira A; Munuera J; Alvarez-Sabin J
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients.
    Sylaja PN; Coutts SB; Subramaniam S; Hill MD; Eliasziw M; Demchuk AM;
    Neurology; 2007 Feb; 68(6):415-9. PubMed ID: 17283315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns.
    Restrepo L; Jacobs MA; Barker PB; Beauchamp NJ; Skolasky RL; Keswani SC; Wityk RJ
    J Neuroimaging; 2005 Jul; 15(3):254-60. PubMed ID: 15951408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke.
    Kosior RK; Wright CJ; Kosior JC; Kenney C; Scott JN; Frayne R; Hill MD
    Cerebrovasc Dis; 2007; 24(4):361-8. PubMed ID: 17690549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR diffusion-weighted imaging and outcome prediction after ischemic stroke.
    Hand PJ; Wardlaw JM; Rivers CS; Armitage PA; Bastin ME; Lindley RI; Dennis MS
    Neurology; 2006 Apr; 66(8):1159-63. PubMed ID: 16525124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
    Comi G; Filippi M; Wolinsky JS
    Ann Neurol; 2001 Mar; 49(3):290-7. PubMed ID: 11261502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.
    Perez A; Restrepo L; Kleinman JT; Barker P; Beauchamp N; Wityk RJ
    J Neuroimaging; 2006 Oct; 16(4):329-33. PubMed ID: 17032382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.
    Barber PA; Parsons MW; Desmond PM; Bennett DA; Donnan GA; Tress BM; Davis SM
    J Neuroimaging; 2004 Apr; 14(2):123-32. PubMed ID: 15095557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
    Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
    Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome.
    Yoo AJ; Barak ER; Copen WA; Kamalian S; Gharai LR; Pervez MA; Schwamm LH; González RG; Schaefer PW
    Stroke; 2010 Aug; 41(8):1728-35. PubMed ID: 20595665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging.
    Warach S; Gaa J; Siewert B; Wielopolski P; Edelman RR
    Ann Neurol; 1995 Feb; 37(2):231-41. PubMed ID: 7847864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citicoline for acute ischemic stroke in Mexican hospitals: a retrospective postmarketing analysis.
    Leon-Jimenez C; Chiquete E; Cantu C; Miramontes-Saldana MJ; Andrade-Ramos MA; Ruiz-Sandoval JL
    Methods Find Exp Clin Pharmacol; 2010 Jun; 32(5):325-30. PubMed ID: 20664823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.
    Xu F; Hongbin Han ; Yan J; Chen H; He Q; Xu W; Zhu N; Zhang H; Zhou F; Lee K
    Drug Deliv; 2011; 18(7):461-7. PubMed ID: 21923252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic values of lesion volume and biochemical markers in ischemic and hemorrhagic stroke: a stereological and clinical study.
    Varoglu AO; Kuyucu M; Demir R; Acemoglu H; Can I; Akcay F
    Int J Neurosci; 2009; 119(12):2206-18. PubMed ID: 19916849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The current state of citicholine in cerebral ischemia].
    Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
    Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study.
    Bang OY; Kim GM; Chung CS; Kim SJ; Kim KH; Jeon P; Saver JL; Liebeskind DS; Lee KH
    Cerebrovasc Dis; 2010; 29(4):328-35. PubMed ID: 20130398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study.
    Thomalla G; Hartmann F; Juettler E; Singer OC; Lehnhardt FG; Köhrmann M; Kersten JF; Krützelmann A; Humpich MC; Sobesky J; Gerloff C; Villringer A; Fiehler J; Neumann-Haefelin T; Schellinger PD; Röther J;
    Ann Neurol; 2010 Oct; 68(4):435-45. PubMed ID: 20865766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.